Andrew Roth, MD, is an Emeritus Member of the Psychiatry Service, Department of Psychiatry & Behavioral Sciences, at Memorial Sloan Kettering Cancer Center (MSK).

Dr. Roth became a clinical fellow in Psycho-Oncology/Consultation-Liaison Psychiatry on the Psychiatry Service at MSK in 1992 after graduating from Mt. Sinai Medical Center’s Psychiatry Residency Program. He joined MSK’s attending staff in 1994, where he served as clinical member and attending psychiatrist through 2022. Dr. Roth concurrently worked as a professor of Clinical Psychiatry at Weill Cornell Medical College (WCMC), Department of Psychiatry, and as an attending psychiatrist at NewYork-Presbyterian Hospital (NYPH).

In 2023, Dr. Roth was appointed to the Emeritus faculty at Memorial Hospital for Cancer and Allied Diseases, Department of Psychiatry & Behavioral Sciences, NYPH’s Department of Psychiatry, and Professor Emeritus of Clinical Psychiatry at WCMC, Cornell University.

Through 2019, Dr. Roth served as both assistant program director and program director for MSK’s ACGME- accredited Psychosomatic Medicine/Psycho-Oncology Clinical Fellowship Training Program. Dr. Roth helped train close to 150 psychiatrists in the subspecialty of psycho-oncology, receiving awards for clinical and teaching excellence.   

He also served as the psychiatry liaison to genitourinary medical oncology at MSK for over 28 years. His research includes the development of the distress thermometer; the creation of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC); a National Cancer Institute-funded, double-blind, randomized control trial using methylphenidate for fatigue in men with prostate cancer; and most recently, evaluation of a novel psychotherapy designed specifically for older cancer patients. He also helped start the Psychiatry Clinical Service at MSK Westchester.